IONIS PHARMACEUTICALS INC
Company Stats
- Market Cap
- $7.4B
- as of Sep 30, 2026
- Shares Outstanding
- 166.2M
- Free Float
- 99.3%
Income Statement
- Revenue
- $943.7M
- Operating Income
- -$381.7M
- Net Income
- -$381.4M
- EBITDA
- -$371.7M
- Non-cash Impairment
- $986,000
- Revenue Growth, 3Y
- 17.1%
- FCF Margin, 3Y Avg
- -51.1%
- FCF Margin, Worst Year
- -77.5%
Cash Flow
- Free Cash Flow
- -$320.0M
- FCF Yield
- -4.3%
- Owner FCF Yield
- -6.1%
Balance Sheet
- Cash & Equivalents
- $372.3M
Returns & Capital
- SBC, 3Y Avg
- $123.3M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $943.7M | -$320.0M | -33.9% |
| FY2024 | $705.1M | -$546.2M | -77.5% |
| FY2023 | $787.6M | -$331.3M | -42.1% |
| FY2022 | $587.4M | -$290.1M | -49.4% |
| FY2021 | $810.5M | $18.8M | 2.3% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 8, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back